Our Future Interests.
To fulfill our mission of contributing to the enrichment of quality of life worldwide through the creation and provision of innovative pharmaceuticals addressing diverse medical needs, we continue to seek partners that match our values, work ethic and commitment to patients. Our focus areas for in-licensing are:
- Cardiovascular and Metabolic Disorders
- Type 2 diabetes and Beta-cell function
- Dyslipidemia and stroke
- Cardiac and kidney dysfunction
- Obesity and peripheral vascular disease
- Oncology
- Pathways implicated in oncogene addiction or therapeutic resistance
- Novel epigenetic or cancer stem cell targets
- Agents synergizing with our existing oncology pipeline
- Novel mechanisms of action (MOAs) that address significant unmet needs
- Late-stage/marketed products requiring strong commercial execution
Click here if you are interested in partnering with us or learning more.
